Mdivi-1(Mitochondrial division inhibitor-1,AbMoel,M2830)是一種線粒體分裂抑制劑,其主要作用靶點(diǎn)是線粒體分裂蛋白Drp1(Dynamin-related protein 1)。Drp1作為線粒體分裂的關(guān)鍵調(diào)控因子,通過(guò)與線粒體膜上的受體蛋白結(jié)合,介導(dǎo)線粒體的分裂過(guò)程。Mdivi-1(CAS No.:338967-87-6)通過(guò)競(jìng)爭(zhēng)性結(jié)合Drp1的GTP酶結(jié)構(gòu)域,抑制其GTP水解活性,從而阻斷Drp1的募集和線粒體分裂復(fù)合物的形成,最終抑制線粒體分裂并促進(jìn)線粒體融合,維持線粒體網(wǎng)絡(luò)的完整性。
在基礎(chǔ)研究中,Mdivi-1的應(yīng)用廣泛并涉及多種模型。Mdivi-1在大鼠模型中,改善了創(chuàng)傷性失血性休克后的器官功能(心、肝、腎、腸)[1]。Mdivi-1在大鼠蛛網(wǎng)膜下腔出血模型中,通過(guò)減輕神經(jīng)功能缺損和腦水腫保護(hù)了血腦屏障[2]。此外,Mdivi-1聯(lián)合Methylprednisolone(U 7532)可促進(jìn)大鼠脊髓損傷后的運(yùn)動(dòng)功能恢復(fù)[3]。Mdivi-1在心血管研究中,抑制了大鼠腸系膜動(dòng)脈和胸主動(dòng)脈的血管收縮,其作用可能與抑制線粒體分裂及平滑肌細(xì)胞功能的調(diào)控相關(guān)[4]。
在細(xì)胞模型中,Mdivi-1可在NIH3T3成纖維細(xì)胞中抑制TGF-β1誘導(dǎo)的纖維化相關(guān)變化[5]。值得注意的是,Mdivi-1對(duì)腫瘤細(xì)胞則表現(xiàn)出多重作用:Mdivi-1在A549(肺癌)細(xì)胞中,緩解了脂多糖(LPS)誘導(dǎo)的線粒體功能障礙和氧化應(yīng)激[6];在8505C(甲狀腺癌)和K1(甲狀腺癌)細(xì)胞中抑制了細(xì)胞的增殖、遷移并促進(jìn)凋亡[7];Mdivi-1還可通過(guò)降低H460、A549(肺癌)和HCT116(結(jié)腸癌)細(xì)胞的線粒體氧化代謝,影響三羧酸循環(huán)活性[8]。
AbMole為全球科研客戶提供高純度、高生物活性的抑制劑、細(xì)胞因子、人源單抗、天然產(chǎn)物、熒光染料、多肽、靶點(diǎn)蛋白、化合物庫(kù)、抗生素等科研試劑,全球大量文獻(xiàn)專利引用。
范例詳解
Phytomedicine. 2024 Dec;135:156088.
四川大學(xué)華西醫(yī)院的實(shí)驗(yàn)人員在上述文章中使用了由AbMole提供的
Mdivi-1(Mitochondrial division inhibitor-1,AbMoel,M2830)抑制了網(wǎng)膜色素上皮(RPE)細(xì)胞的線粒體分裂?蒲腥藛T發(fā)現(xiàn)Melatonin(褪黑素) 可通過(guò)調(diào)節(jié)MT2/SERCA2/Ca²⁺軸保護(hù)視網(wǎng)膜色素上皮(RPE)細(xì)胞免受碘酸鈉(SI)誘導(dǎo)的損傷。細(xì)胞實(shí)驗(yàn)的結(jié)果表明,SI通過(guò)激活內(nèi)質(zhì)網(wǎng)應(yīng)激和細(xì)胞內(nèi)鈣超載誘導(dǎo)RPE細(xì)胞壞死性凋亡和NLRP3炎癥小體激活,而褪黑素預(yù)處理可通過(guò)激活MT2受體恢復(fù)SERCA2功能,抑制線粒體鈣超載和分裂,從而減輕RPE細(xì)胞死亡和炎癥反應(yīng)。在C57BL/6小鼠視網(wǎng)膜變性模型中,Melatonin可維持視網(wǎng)膜結(jié)構(gòu)的完整性并保護(hù)視覺(jué)功能,為年齡相關(guān)性黃斑變性(AMD)的抑制提供了新靶點(diǎn)[9]。
2014年,AbMole的兩款抑制劑分別被西班牙國(guó)家心血管研究中心和美國(guó)哥倫比亞大學(xué)用于動(dòng)物體內(nèi)實(shí)驗(yàn),相關(guān)科研成果發(fā)表于頂刊 Nature 和 Nature Medicine。

Mitochondrial Ca2+ overload promotes necroptosis of RPE cells through inducing mitochondrial fission.
*本文所述產(chǎn)品僅供科研使用
參考文獻(xiàn)及鳴謝
[1] Hu, Y.; Fang, H.; Tan, L.; et al. THE MITOCHONDRIAL DIVISION INHIBITOR MDIVI-1 PROTECTED ORGAN FUNCTION AND EXTENDED THE TREATMENT WINDOW IN RATS WITH UNCONTROLLED HEMORRHAGIC SHOCK. Shock (Augusta, Ga.) 2025, 63 (3), 474-486,
[2] Wu, P.; Li, Y.; Zhu, S.; et al. Mdivi-1 Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats, Possibly via Inhibition of Drp1-Activated Mitochondrial Fission and Oxidative Stress. Neurochemical research 2017, 42 (5), 1449-1458,
[3] Chen, X. G.; Chen, L. H.; Xu, R. X.; et al. Effect evaluation of methylprednisolone plus mitochondrial division inhibitor-1 on spinal cord injury rats. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2018, 34 (8), 1479-1487,
[4] Chen, C.; Gao, J. L.; Liu, M. Y.; et al. Mitochondrial Fission Inhibitors Suppress Endothelin-1-Induced Artery Constriction. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017, 42 (5), 1802-1811,
[5] Ding, J.; Zhang, Z.; Li, S.; et al. Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-Activated mitochondrial fission and oxidative stress. Archives of biochemistry and biophysics 2022, 718, 109147,
[6] Luo, X.; Liu, R.; Zhang, Z.; et al. Mitochondrial Division Inhibitor 1 Attenuates Mitophagy in a Rat Model of Acute Lung Injury. BioMed research international 2019, 2019, 2193706,
[7] Zhang, L.; Sun, L.; Wang, L.; et al. Mitochondrial division inhibitor (mdivi-1) inhibits proliferation and epithelial-mesenchymal transition via the NF-kappaB pathway in thyroid cancer cells. Toxicology in vitro : an international journal published in association with BIBRA 2023, 88, 105552,
[8] Dai, W.; Wang, G.; Chwa, J.; et al. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. British journal of cancer 2020, 122 (9), 1288-1297,
[9] Ren, C.; Hu, C.; Hu, M.; et al. Melatonin protects RPE cells from necroptosis and NLRP3 activation via promoting SERCA2-related intracellular Ca(2+) homeostasis. Phytomedicine : international journal of phytotherapy and phytopharmacology 2024, 135, 156088,